Evidence map›Paper›PMID 40585705›Full record

ReviewCureus2025

Exploring the Association Between Myocardial Infarction and Cognitive Decline: A Narrative Review.

Iqrah A Issimdar, Rohit Mudegowdar, Anchal R Gupta, Keval B Patel, Anas Elshoura, Vidhi Mahendra Bhanushali, Joshua R Joseph, Aishwarrya Meiyalagan Varalakshmi, Monika Sahotra, Mazin Kashif and 3 more

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Iqrah A IssimdarHealth and Agriculture, University College Dublin, Dublin, IRL.
Rohit MudegowdarInternal Medicine, JJM Medical College, Davanagere, IND.
Anchal R GuptaInternal Medicine, Royal Shrewsbury Hospital, Shrewsbury, GBR.
Keval B PatelSurgery, Narendra Modi Medical College, Ahmedabad, IND.
Anas ElshouraNeurosurgery, South Tees Hospitals, Newcastle, GBR.
Vidhi Mahendra BhanushaliMedical Education, Lincoln American University, Georgetown, GUY.
Joshua R JosephInternal Medicine, Medical University of Varna, Varna, BGR.
Aishwarrya Meiyalagan VaralakshmiDepartment of Medicine, Jawaharlal Nehru Medical College, Belagavi, IND.
Monika SahotraDepartment of Medicine, Bukovinian State Medical University, Chernivtsi, UKR.
Mazin KashifCardiology, University College Cork, Cork, IRL.
Vivasvat BinnyScience, Gretchen Whitney High School, Cerritos, USA.
Nahila A PathanFamily Medicine, American University of Antigua, Osbourn, ATG.
Humza F SiddiquiInternal Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between cognitive impairment (CI) and myocardial infarction (MI) has been highlighted in recent years. Several studies have reported an increased incidence of cognitive decline (CD) following MI, emphasizing the need for early identification and intervention in such patients. Previous research findings have been inconsistent due to the presence of various unaccounted factors potentially contributing to CD and disparities in the methods utilized to assess cognition such as the Mini-Mental State Examination, Mini-Cog and self-evaluation questionnaires. This emphasizes the potential for a more standardized tool of assessment to investigate the onset of CD amongst MI patients in a reliable manner. This literature review delineates the correlation between MI and CI, exploring the pathogenesis, risk factors, management and preventive strategies. Cerebral hypoperfusion, underlying atherosclerosis and neuroinflammation are crucial in the development of CD after MI. Hence, it is important to consider the 'heart-brain axis' for targeted therapy of CD in MI patients. Old age is a common risk factor for CD and MI. However, the impact of variables including gender and comorbidities is underreported, which can potentially alter the relationship between cognitive outcomes and MI. The implementation of multidisciplinary-oriented cardiac rehabilitation programs and a universal screening tool to follow up on patients with established CI post-MI has shown favorable outcomes and has reduced the risk of adverse health consequences. Optimizing medical management and regular monitoring of serum brain natriuretic peptide (BNP) and hemoglobin levels are essential in preventing CD after MI. Psychological evaluation and counselling also help attenuate CD. Additionally, preventive strategies addressing modifiable risk factors and implementing anti-inflammatory diets have proven beneficial. Ongoing research is focused on the study of novel interventions targeting the neuroinflammatory process. Recently a new member of the C-reactive protein family, pentraxin 3, has been identified as a specific vascular inflammatory biomarker produced by cells in atherosclerotic lesions that can potentially aid in recognizing CD. It is imperative to establish uniform guidelines to recognize and manage CI among patients following MI to improve quality of life among the elderly population.

Indexed as

acute myocardial infarction (ami)cognitive declinecognitive impairmentdementiamyocardial infarctionpost-acute myocardial infarction

Identifiers

PMID40585705
PMCPMC12203756

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.